Skip to Main Content

Paper Details

Eplerenone for the treatment of chronic central serous chorioretinopathy: 3-year clinical experience.
Br J Ophthalmol
17
2020
Author NameAffiliation
Grant L HomCenter for Ophthalmic Bioinformatics, Cleveland Clinic Cole Eye Institute
Sumit SharmaCleveland Clinic Cole Eye Institute
Rishi P SinghCole Eye Institute, Cleveland Clinic
  • 1 - 3

Datasets

Release 1.2